COST EFFECTIVENESS OF H PYLORI 'TEST AND TREAT' VERSUS PPI FOR UNINVESTIGATED DYSPEPSIA: MODELLING AND META-ANALYSIS IN THE DESIGN OF THE MRC-CUBE TRIAL
- Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia. Fauli, Siri; Thue, Geir // European Journal of Health Economics;Sep2008, Vol. 9 Issue 3, p221
We have developed a model for economic evaluation related to the diagnostic accuracy (sensitivity and specificity) of near patient tests used in office laboratories, as opposed to using hospital-based tests. Blood-sample based tests to detect the bacterium Helicobacter Pylori (HP) are useful in...
- Test-and-Treat Strategy for Dyspepsia Is Supported. Walling, Anne D. // American Family Physician;8/15/2002, Vol. 66 Issue 4, p660
Presents an abstracts of studies on dyspepsia. 'Treating Helicobacter pylori in Primary Care Patients With Uninvestigated Dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment--Helicobacter pylori Positive (CADET-Hp) Randomised Controlled Trial,' by N. Chiba et al., from the April 27, 2002...
- Chronic Gastritis in Dermatitis Herpetiformis: A Controlled Study. Alakoski, Anna; Salmi, Teea T.; Hervonen, Kaisa; Kautiainen, Hannu; Salo, Maarit; Kaukinen, Katri; Reunala, Timo; Collin, Pekka // Clinical & Developmental Immunology;2012, p1
Background and Objective. Previous small studies suggest that chronic atrophic gastritis is common in dermatitis herpetiformis (DH). We here examined the frequency and topography of chronic gastritis in 93 untreated DH subjects and in 186 controls with dyspepsia. Methods. Specimens were drawn...
- NONULCER DYSPEPSIA: HELICOBACTOR PYLORI OR IDIOPATHY? Kozol, Robert A. // American Journal of Gastroenterology;Mar1996, Vol. 91 Issue 3, p419
Discusses an overview of studies on anti-Helicobacter pylori therapy in patients with functional or non ulcer dyspepsia. Advantage of the eradication of Helicobacter pylori in patients with peptic ulcer; Result of clinical trials of anti-Helicobacter pylori therapy; Strengths of the study...
- HELICOBACTER PYLORI IN PEDIATRIC NONULCER DYSPEPSIA: PATHOGEN OR COMMENSAL? Tolia, Vasundhara // American Journal of Gastroenterology;Jun1995, Vol. 90 Issue 6, p865
Discusses the role of Helicobacter pylori in pediatric non-ulcer dyspepsia. Mucosal abnormalities in the gastrointestinal tract; Details of studies that demonstrated significant and sustained symptomatic improvement in children with H. pylori gastritis after treatment; Evaluation of results of...
- Pooling data on different probiotics is not appropriate to assess the efficacy of probiotics. Szajewska, Hania // European Journal of Pediatrics;Jul2014, Vol. 173 Issue 7, p975
A letter to the editor is presented in response to the article "Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children" by S. Li and colleagues.
- One day treatment is as effective as seven to eradicate H pylori. // BMJ: British Medical Journal (International Edition);3/13/2004, Vol. 328 Issue 7440, p592
Discusses whether a one day treatment of Helicobacter pylori is as effective as a seven day regimen in patients with dyspepsia. Rates of treatment success; Treatment side effects.
- Influence of Helicobacter pylori infection on in vitro responsiveness of gastric fundus to agonists and to stimulation of enteric nerves in Mongolian gerbils. Takehara, Yusuke; Mizuta, Yohei; Isomoto, Hajime; Ohnita, Ken; Yoshimura, Masaya; Nakamura, Takashi; Takeshima, Fuminao; Omagari, Katsuhisa; Murase, Kunihiko; Murata, Ikuo; Taniyama, Kohtaro; Kohno, Shigeru // Journal of Gastroenterology;2002, Vol. 37 Issue 8, p589
Background. It has recently been proposed that disturbed gastric adaptive relaxation may play a role in functional dyspepsia (FD). However, the effect of Helicobacter pylori infection, which may be one of multiple factors associated with FD, on gastric relaxation is not clear. The aim of this...
- AKT answer relating to management of dyspepsia. // InnovAiT;Apr2011, Vol. 4 Issue 4, p244
The article offers information on how to manage dyspepsia which involves the use of a proton pump inhibitor (PPI) or test and treat for helicobacter pylori (H. pylori) and the prescription of a prokinetic or an H2-receptor antagonist for one month.